Chemical Pollution ‘Messing’ with Female Metabolic Processes: Commentary

[Comment: When will the pharmaceutical industry and their feminist sales force – left-wing women’s groups – stop messing with women’s bodies by pushing sales of steroidal hormones (used in menopausal therapy and oral contraceptives)? Drug companies are apparently searching for a way that women can continue using hormone replacement therapy, but there are health risks associated with the use of these drugs. Unpatentable products, on the other hand, do not have the same money-making potential as do patented products. Some natural products are alternatives to hormone replacement therapy. These non-estrogen products relieve menopausal symptoms and, unlike hormone replacement therapy, they aren’t associated with the risks of heart disease, stroke and breast and uterine cancers.    Karen Malec,  Coalition on Abortion/Breast Cancer]   ABORTION-BREAST CANCER NEWS HEADLINES “‘Safe Window’ Allegedly Found for Hormone Replacement Therapy” Four years ago, the Women’s Health Initiative (WHI), a government-funded study, ended prematurely when researchers said they found that use of combined hormone replacement therapy (HRT) – synthetic estrogens and progestin – raises risk of heart attacks, strokes and breast cancers. The WHI’s 2002 findings were widely publicized and women rushed to their doctors to find some alternative to HRT for the relief of menopausal symptoms. Different cancer risks are associated with the use of combined HRT and oral contraceptives (OCs) versus estrogen-only HRT and OCs. Doctors generally prescribe estrogen-only HRT to women with hysterectomies, but not to women who still have their wombs. Researchers learned in the 1970s that estrogen-only OCs increase the risk of uterine cancer. Progestins (progesterone-like hormones) were added to estrogen-only HRT and OCs because they did not increase uterine cancer risk....